Trial intelligence / Profile preview

Zhuanggu joint Capsules with or without celecoxib for knee osteoarthritis

ChiCTR-IPR-15007267Phase 4Completed

Sponsor
Shanghai Sixth People's Hospital
Start
Nov 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of celecoxib in knee osteoarthritis (OA) (3 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Started Nov 2012; status: completed.

02

Drugs

celecoxib
03

Conditions

knee osteoarthritis (OA)

Beyond the preview

Go deeper on ChiCTR-IPR-15007267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-IPR-15007267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call